Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Scotland

Funding for Scottish pharmacies to rise by £2.6m

Rose Marie Parr, Scottish chief pharmaceutical officer

Source: Source: Simon Wright Photography/The Pharmaceutical Journal

Rose Marie Parr, Scottish chief pharmaceutical officer, has announced a £2.6m increase in funding for community pharmacies in Scotland

Community pharmacies in Scotland are to receive an increase in funding of £2.6m in 2018–2019.

The new global sum has been set at £180.96m, an increase of 1.46% on the previous two years.

The announcement, made in a letter from Rose Marie Parr, Scottish chief pharmaceutical officer and deputy director of the pharmacy and medicines division in the Scottish government’s healthcare quality and strategy directorate, said the settlement would also move £20m from the drug tariff into the global sum for this year, meaning guaranteed funding for Scottish community pharmacies of £200.96m for 2018–2019.

The new arrangements also reset the guaranteed minimum margin retained by community pharmacies to £100m. Any amount earned above this will be shared between pharmacies and NHS boards.

Parr’s letter said the government will claw back around £5m of margin earned in 2017–2018, with generic clawback applied at 1.5% from 1 June 2018. But the clawback would be temporarily suspended or adjusted in case of ‘market deterioration’.

In a statement, Community Pharmacy Scotland said: “This settlement will reduce the reliance on reimbursement on the cost of medicines and continue the process of developing our contractual arrangements to reflect funding alongside appropriate service provision to the Scottish population. In the short term we will work with the department to allocate the Global Sum within 2018–2019.

“Over the next few years we will look to continue to work collaboratively to develop services which support our vision and place community pharmacy as a key contributor within primary care.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205020

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Rose Marie Parr, Scottish chief pharmaceutical officer

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.